Novartis Drug Diovan Shows Superior Benefits
Results of a Japanese study have given drug giant Novartis AG, more reasons to smile. According to the study published in The Lancet, the company’s blood pressure// drug Diovan was observed to reduce the risks of strokes and cardiovascular events by up to 40 percent. The study titled the Jikei Heart Study, was based on 3,000 people aged 20 to 79, with high blood pressure, ischemic hea...Diovan Achieved 40% Reduction in Stroke and Cardiovascular Events in Landmark Jikei Heart Study
<p style="MARGIN: 0in 0in 0pt; TEXT-ALIGN: left; tab-stops: 0in"align="left"> <li style="MARGIN: 0in 0in 0pt; tab-stops: list .5in; mso-list: l1 level1 lfo2"> <span style="FONT-SIZE: 11pt; FONT-FAMILY: 'News Gothic MT'; mso-bidi-font-weight: bold">Independent Japanese study demonstrates dramati...Diovan Achieved 40% Reduction in Stroke and Cardiovascular Events in Landmark Jikei Heart Study
Independent Japanese study demonstrates dramaticbenefits of adding Diovan to conventional therapy Study halted early due to superior outcomes forDiovan patients BASEL,Switzerland, April 27, 2007 - New findings from th...